no key · no human

Pharmexec API, RSS and sitemap

Every article Pharmexec publishes, as JSON, through an open API with no key and no signup. 494 of their articles are indexed right now, refreshed hourly.

United States#9,224 by volume

Four ways to pull pharmexec.com

All four are ours, all four are live, and none of them needs a key.

JSON Search this publisher

Every article we hold from pharmexec.com, newest first. Add q= to search inside.

curl -s "https://freenewsapi.ai/v1/search?host=www.pharmexec.com&size=20"open it →

RSS Subscribe in any reader

The same articles as an RSS 2.0 feed. Works in Feedly, Inoreader, Thunderbird — anywhere.

curl -s "https://freenewsapi.ai/v1/rss?host=www.pharmexec.com&size=50"open it →

JSON Feed For apps

JSON Feed 1.1, the same content in a format apps parse natively.

curl -s "https://freenewsapi.ai/v1/feed.json?host=www.pharmexec.com&size=50"open it →

Trimmed For agents

Only the fields an agent needs — title, url, date, language — so the response stays small.

curl -s "https://freenewsapi.ai/v1/search?host=www.pharmexec.com&size=20&fields=title,url,published_at,lang"open it →

What this outlet covers, by share of its recent output:

health 60%business 20%technology 20%

Call the API

A live request. Paste it into a terminal and Pharmexec headlines come back as JSON.

bash
curl "https://freenewsapi.ai/v1/search?host=www.pharmexec.com&size=5"
494
articles indexed
196
in the last 30 days
10
median per day
0
languages
2529 min
median crawl lag
20.08 → 18.09
archive depth

Publishing volume

Articles per day over the last 20 days. The busiest hour is 10:00 UTC — that is when the newsroom pushes its main batch.

2026-08-20: 1 articles2026-08-21: 5 articles2026-08-24: 10 articles2026-08-25: 14 articles2026-08-26: 16 articles2026-08-27: 12 articles2026-08-28: 10 articles2026-08-31: 8 articles2026-09-01: 24 articles2026-09-02: 12 articles2026-09-03: 12 articles2026-09-04: 10 articles2026-09-09: 7 articles2026-09-10: 7 articles2026-09-11: 7 articles2026-09-14: 8 articles2026-09-15: 6 articles2026-09-16: 7 articles2026-09-17: 8 articles2026-09-18: 13 articles08-2008-2508-2809-0209-0909-1409-1709-18
bash
curl "https://freenewsapi.ai/v1/stats?host=www.pharmexec.com&top=10"

Publishing rhythm

When Pharmexec actually publishes, by hour of day (UTC) and by day of week — measured from 494 timestamps, not from a schedule they advertise.

00: 00001: 00102: 00203: 00304: 10405: 00506: 00607: 00708: 00809: 20910: 721011: 41112: 81213: 461314: 71415: 101516: 11617: 171718: 131819: 161920: 02021: 02122: 02223: 023
Mon: 26MonTue: 44TueWed: 42WedThu: 40ThuFri: 45FriSat: 0SatSun: 0Sun

Latest articles

The 18 most recent Pharmexec articles in the index — the same rows the API returns, rendered for humans.

<![CDATA[Pharmaceutical Executive Daily: FDA Approves Fayuvi]]>
2026-09-18 19:06 UTC
<![CDATA[FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners wit
<![CDATA[Omnideployment: The Future of Pharmaceutical Commercialization]]>
2026-09-18 15:51 UTC
<![CDATA[Omnichannel is no longer enough. Learn how omnideployment integrates AI, content, digital marketing and field engagement into a single accountable system that dr
<![CDATA[Beyond AI-Enabled: Why a New Partner Model is Vital for Pharmaceutical Marketing in Europe]]>
2026-09-18 15:51 UTC
<![CDATA[Being AI-enabled is no longer enough. Learn how AI-native commercialization partners can help pharmaceutical companies orchestrate intelligence across markets, n
<![CDATA[Beyond the Data: Why Scientific Storytelling Will Define the Future of Medical Communications]]>
2026-09-18 15:51 UTC
<![CDATA[Scientific storytelling is becoming a critical differentiator in Medical Affairs. Discover how leading organizations are moving beyond standalone assets and data
<![CDATA[From Direct-to-Patient to Direct-to-Disease: New Commercialization Models in Europe]]>
2026-09-18 15:51 UTC
<![CDATA[The future of commercialization extends beyond product promotion and patient acquisition. Learn how Direct-to-Disease models enable pharmaceutical companies to b
<![CDATA[M&A Roundup: Lisata Therapeutics Acquires Marea Therapeutics, mAbxience Enters Collaboration with Sandoz ]]>
2026-09-18 13:37 UTC
<![CDATA[Lisata Therapeutics acquires Marea Therapeutics and secures $225 million in concurrent financing, while mAbxience and Sandoz partner to develop and globally comm
<![CDATA[FDA Approves Fayuvi for Pediatric Patients with Sanfilippo Syndrome Type A]]>
2026-09-18 13:21 UTC
<![CDATA[FDA approved Ultragenyx's Fayuvi (rebisufligene etisparvovec-hopf) as the first treatment for MPS IIIA Sanfilippo syndrome type A.]]>
<![CDATA[Why Executive MFN Deals Aren't Enough: Q&A with Joe Cunningham]]>
2026-09-18 11:00 UTC
<![CDATA[Former Rep. Joe Cunningham (D-SC), now spokesperson for the Pharmaceutical Reform Alliance, argues that codifying Most-Favored-Nation pricing into law is the rea
<![CDATA[Addressing MFN Innovation Concerns]]>
2026-09-18 11:00 UTC
<![CDATA[Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance. dismisses the pharmaceutical industry's innovation argument again
<![CDATA[RWD's Impact on Clinical Trial Recruitment Costs]]>
2026-09-18 10:00 UTC
<![CDATA[Inovalon's Jen Lamppa on why inaccurate self-reported data is clinical trial enrollment's costliest problem — and how RWD fixes it.]]>
<![CDATA[Your Questions Answered: AI Drug Discovery, Portfolio Simplification, and a 30-Year First]]>
2026-09-18 10:00 UTC
<![CDATA[Five major pharma stories in one day — Novo's rebrand and AI bets, Bayer's 30-year CKD first, GSK's T-cell engager, and Sanofi's portfolio exit.]]>
<![CDATA[The Shift Towards a Patient-Centric Culture in Pharma]]>
2026-09-18 10:00 UTC
<![CDATA[Inizio's Elaine Ferguson on why enabling purpose-driven employees to make a meaningful difference is as important as any formal talent strategy.]]>
<![CDATA[Understanding the Latest with MFN Pricing and What It Means to Pharma]]>
2026-09-18 10:00 UTC
<![CDATA[EVERSANA's Alan Crowther on why MFN's three programs, compounding interactions with IRA and 340B, and leverage gaps make it pharma's most consequential pricing c
<![CDATA[Pharmaceutical Executive Daily: FDA Approves New Indication for Kerendia]]>
2026-09-17 19:19 UTC
<![CDATA[FDA approves Kerendia as the first new treatment for kidney disease in type 1 diabetes in decades, Novo, Roche, and Aethlon Medical strike major deals and merger
<![CDATA[The Battle to Own the GLP-1 Patient Journey]]>
2026-09-17 15:18 UTC
<![CDATA[As GLP-1 competition shifts from molecules to prescriptions, manufacturers, pharmacies, providers, and payers are racing to own the patient journey.]]>
<![CDATA[Roundup: Orbis Enters $1.4 Billion Partnership with Novo, Dualitas Therapeutics Enters Research collaboration w
2026-09-17 13:54 UTC
<![CDATA[Orbis Medicines strikes a partnership with Novo, Dualitas Therapeutics enters collaboration with Roche, and Aethlon Medical has agreed to merge with North Immuno
<![CDATA[FDA Approves Kerendia for Adults with Chronic Kidney Disease and Type 1 Diabetes ]]>
2026-09-17 13:27 UTC
<![CDATA[FDA has approved Bayer's Kerendia to reduce disease progression risk in adults with chronic kidney disease associated with type 1 diabetes.]]>
<![CDATA[The Realistic Path to Making MFN Pricing Permanent]]>
2026-09-17 11:00 UTC
<![CDATA[Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance, touches on what he sees as the most realistic path to making MFN

Harvest it all

Page through the archive by date. from and to accept YYYY-MM-DD or relative values such as now-7d.

bash
curl "https://freenewsapi.ai/v1/search?host=www.pharmexec.com&from=now-7d&size=100"

To poll for new material, keep the timestamp of the newest article you saw and ask only for what came after it:

bash
curl "https://freenewsapi.ai/v1/search?host=www.pharmexec.com&from=now-1h&sort=date_asc"

Article bodies come with full_text=true. No key, no quota tier, no header — see the search endpoint for every parameter.

Metadata quality

How well Pharmexec marks up its own pages — useful if you are deciding whether to parse them yourself.

0%
dates from JSON-LD
0%
articles with a byline
0%
articles with sections
—
average page weight

Crawl lag — the delay between publication and the article reaching this index — is 2529 min at the median, 7616 minutes at the 90th percentile.

FAQ

Does Pharmexec have an official API?

Not a public one. This endpoint is the practical alternative: their articles as structured JSON, with title, lead, publication time, section, byline and a link back to the original.

How do I get their RSS feed?

Most publishers expose one at /rss or /feed, but feeds carry only the last few dozen items and drop them within hours. This index keeps 494 of their articles and lets you filter by date, language and section.

How many articles does Pharmexec publish per day?

10 on a median day, measured across 20 days.

Can I use this commercially?

The API is free and unauthenticated. What you may do with the content is between you and the publisher: we return metadata, a lead paragraph and a link, not a licence.